EIF4HP2: A Potential Drug Target and Biomarker (G100421545)

EIF4HP2: A Potential Drug Target and Biomarker

EIF4HP2 (endoplasmic reticulum-associated protein 4-h2) is a protein that is expressed in various tissues and cells, including the brain, heart, and gastrointestinal tract. It is involved in the regulation of protein synthesis, localization, and degradation, which are critical processes for maintaining cellular homeostasis and cell survival. The identification of potential drug targets and biomarkers is an important step in drug development, and EIF4HP2 is a promising candidate for both.

Drug Target Potential

EIF4HP2 has been shown to play a role in various cellular processes that are crucial for cell survival, such as cell signaling, apoptosis, and autophagy. It is involved in the regulation of protein synthesis and localization, which are critical for the production and delivery of proteins that are essential for cellular function. EIF4HP2 has also been shown to be involved in the regulation of protein degradation, which is critical for maintaining cellular homeostasis and preventing excessive protein synthesis that can lead to toxicity.

In addition to its role in protein synthesis and degradation, EIF4HP2 has also been shown to play a role in cell signaling. It is involved in the regulation of several signaling pathways, including the regulation of cell adhesion, the regulation of ion channels, and the regulation of protein signaling. EIF4HP2 has also been shown to play a role in modulating the activity of several signaling pathways, including the regulation of the production and localization of proteins that are involved in cell signaling.

EIF4HP2 has also been shown to be involved in the regulation of apoptosis, which is a critical process for cell death and disposal. EIF4HP2 has been shown to play a role in the regulation of apoptosis by modulating the activity of several genes that are involved in cell apoptosis.

Biomarker Potential

EIF4HP2 has also been shown to be involved in the regulation of several biomarkers that are involved in cellular function. It is involved in the regulation of protein synthesis and localization, which are critical for the production and delivery of proteins that are involved in cellular function. EIF4HP2 has also been shown to play a role in the regulation of protein degradation, which is critical for maintaining cellular homeostasis and preventing excessive protein synthesis that can lead to toxicity.

In addition to its role in protein synthesis and degradation, EIF4HP2 has also been shown to play a role in the regulation of several biomarkers that are involved in cellular function. It is involved in the regulation of cell adhesion, which is critical for the maintenance of tissue structure and function. EIF4HP2 has also been shown to play a role in the regulation of ion channels, which are critical for the regulation of electrical potential in cells.

Conclusion

In conclusion, EIF4HP2 is a protein that is involved in various cellular processes that are critical for cell survival and homeostasis. Its involvement in the regulation of protein synthesis and localization, apoptosis, and biomarkers suggests that it may be a valuable drug target and biomarker. Further research is needed to confirm its potential as a drug target and biomarker.

Protein Name: Eukaryotic Translation Initiation Factor 4H Pseudogene 2

The "EIF4HP2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EIF4HP2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

EIF5 | EIF5A | EIF5A2 | EIF5AL1 | EIF5B | EIF6 | EIPR1 | ELAC1 | ELAC2 | ELANE | ELAPOR1 | ELAPOR2 | Elastase | ELAVL1 | ELAVL2 | ELAVL3 | ELAVL4 | ELDR | ELF1 | ELF2 | ELF2P4 | ELF3 | ELF3-AS1 | ELF4 | ELF5 | ELFN1 | ELFN1-AS1 | ELFN2 | ELK1 | ELK2AP | ELK3 | ELK4 | ELL | ELL2 | ELL2P1 | ELL3 | ELMO1 | ELMO2 | ELMO3 | ELMOD1 | ELMOD2 | ELMOD3 | ELN | ELOA | ELOA-AS1 | ELOA2 | ELOA3BP | ELOA3DP | ELOA3P | ELOB | ELOC | ELOF1 | Elongation Factor 1 Complex | Elongation of very long chain fatty acids protein | Elongin (SIII) complex | ELOVL1 | ELOVL2 | ELOVL2-AS1 | ELOVL3 | ELOVL4 | ELOVL5 | ELOVL6 | ELOVL7 | ELP1 | ELP2 | ELP3 | ELP4 | ELP5 | ELP6 | ELSPBP1 | EMB | EMBP1 | EMC1 | EMC1-AS1 | EMC10 | EMC2 | EMC3 | EMC3-AS1 | EMC4 | EMC6 | EMC7 | EMC8 | EMC9 | EMCN | EMD | EME1 | EME2 | EMG1 | EMID1 | EMILIN1 | EMILIN2 | EML1 | EML2 | EML2-AS1 | EML3 | EML4 | EML4-AS1 | EML5 | EML6 | EMP1